Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine

Rheumatology

Volumn 47, Issue 11, 2008, Pages 1734-1735

  Juarez, Maria ^a   Marshall, R ^a   Denton, C ^b   Evely, R ^c  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CLADRIBINE;

ADULT; ANTIBODY DETECTION; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; LETTER; MALE; MONONUCLEAR CELL; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SCLERODERMA;

CLADRIBINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; SCLERODERMA, LOCALIZED;

EID: 54449096634     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken367     Document Type: Letter

References (10)

1. Sfikaskis PP, Gorgoulis VG, Katsiari CG, Evangelou K, Kostopoulos C, Black CM. Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology 2008;47:735-7.
2. Kochhar R, Umbreit JN. Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient. Clin Rheumatol 2004; 23:269-71.
3. Yamamoto M, Suzuki C, Naishiro et al. [A case of pseudoscleroderma as paraneoplastic syndrome due to carcinoma of cervical uteri]. Nihon Rinsho Meneki Gakkai Kaishi 2003;26:293-8 (in Japanese).
4. Campoy Martinez P, Grilo Reina A, Camacho Martinez E, Rivera Civico JM, Garcia Perez M, Garcia Bragado F. [Scleroderma as a paraneoplastic syndrome of ductal carcinoma of the prostate]. Arch Esp Urol 1994;47:616-8 (in Spanish).
5. Blanche P, Bachmeyer C, Mikdame M, Dreyfus F, Sciard D. Scleroderma, polymyositis, and hairy cell leukaemia. J Rheumatol 1995;22:1384-5.
6. Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D. Rheumatic syndromes: Clues to occult neoplasia. Semin Arthritis Rheum 1999;29:43-55.
7. Tallman MS. Clinical features and diagnosis of hairy cell leukemia. UpToDate. September 2006.
8. Denton CP. Pathogenesis of systemic sclerosis (scleroderma). UpToDate. February 2008.
9. Varga J, Jimenez SA. Modulation of collagen gene expression: Its relation to fibrosis in systemic sclerosis and other disorders. Ann Intern Med 1995;122:60-2.
10. Robak T, Korycka A, Robak E. Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies. Recent Pat Anticancer Drug Discov 2006;1:23-38.